Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
3
×
national top stories
boston
boston blog main
boston top stories
national
san diego blog main
astellas pharma
atlas venture
audentes therapeutics
avidity biosciences
bluebird bio
clinical trials
duchenne muscular dystrophy
dyne therapeutics
event
facioscapulohumeral muscular dystrophy
gene therapy
joshua brumm
kaleido biosciences
life science
muscular dystrophy
myotonic dystrophy type 1
new york blog main
rare disease drugs
romesh subramanian
san diego
san diego top stories
san francisco blog main
susanna high
vertex pharmaceuticals
xcelerating life sciences
xconsd
What
early
3
×
bird
breakthroughs
life
sciences
xcelerating
accelerating
ago
attend
biomedical
biopharma's
biopharma’s
biotechs
boston
conference
considering
data
diego’s
digital
diseases
drug
dyne
ending
ends
expected
experimental
eyes
future
genetic
genomics
having
health
humans
ipo
ipos
learn
long
lowest
march
medical
Language
unset
3
×
Current search:
early
×
unset
×
" national blog main "
×
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com
4 years ago
Early Bird Sale Ends Today for Xcelerating Life Sciences Boston: Biopharma’s Future in Digital Health
@xconomy.com
4 years ago
Early Bird Sale Ending for San Diego’s Xcelerating Life Sciences Conference